Marc Schegerin
Financieel Directeur/CFO bij MORPHIC HOLDING, INC.
Vermogen: 1 M $ op 31-05-2024
Profiel
Marc Schegerin is currently an Independent Director at SQZ Biotechnologies Co., Chief Financial & Operating Officer at Morphic Therapeutic, Inc., and Chief Operating & Financial Officer at Morphic Holding, Inc. Previously, he worked as a Program Director at Biogen, Inc. from 2009 to 2013, a Director at Citigroup, Inc. from 2016 to 2018, a Senior Director at SAGE Therapeutics, Inc. from 2013 to 2014, and as the Chief Financial Officer, Treasurer & Head-Strategy at ArQule, Inc. from 2019 to 2020.
He obtained his undergraduate degree from Tulane University (Louisiana), a doctorate from Dartmouth Medical School, an MBA from Tuck School of Business at Dartmouth, and another undergraduate degree from Harvard University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
MORPHIC HOLDING, INC.
0.07% | 01-04-2024 | 37 907 ( 0.07% ) | 1 M $ | 31-05-2024 |
| 31-12-2023 | 0 ( -.--% ) | - $ | 31-05-2024 |
Actieve functies van Marc Schegerin
| Bedrijven | Functie | Begin |
|---|---|---|
| MORPHIC HOLDING, INC. | Financieel Directeur/CFO | 06-04-2020 |
| SQZ BIOTECHNOLOGIES COMPANY | Directeur/Bestuurslid | 23-10-2020 |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Financieel Directeur/CFO | 01-04-2020 |
Eerdere bekende functies van Marc Schegerin
| Bedrijven | Functie | Einde |
|---|---|---|
| ARQULE, INC. | Financieel Directeur/CFO | 01-01-2020 |
| CITIGROUP INC. | Directeur/Bestuurslid | 01-04-2018 |
| SAGE THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-01-2014 |
| BIOGEN INC. | Corporate Officer/Principal | 01-01-2013 |
Opleiding van Marc Schegerin
| Dartmouth Medical School | Doctorate Degree |
| Tuck School of Business at Dartmouth | Masters Business Admin |
| Tulane University (Louisiana) | Undergraduate Degree |
| Harvard University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 5 |
|---|---|
| MORPHIC HOLDING, INC. | Health Technology |
| SQZ BIOTECHNOLOGIES COMPANY | Health Technology |
| CITIGROUP INC. | Finance |
| BIOGEN INC. | Health Technology |
| SAGE THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA. | Health Technology |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Health Technology |
